Valuation: Compugen Ltd.

Market Cap 226M 199M 184M 169M 320M 21.62B 327M 2.2B 859M 10.62B 849M 830M 36.72B P/E 2026 *
-7.93x
P/E 2027 * -8.04x
Enterprise Value 226M 199M 184M 169M 320M 21.62B 327M 2.2B 859M 10.62B 849M 830M 36.72B EV / Sales 2026 *
24x
EV / Sales 2027 * 14.1x
Free-Float
97.92%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Compugen Ltd.

1 day-3.77%
1 week+0.88%
Current month+7.48%
1 month+12.75%
3 months-10.85%
6 months+16.16%
Current year+50.33%
1 week 2.29
Extreme 2.29
2.56
1 month 1.96
Extreme 1.96
2.56
Current year 1.51
Extreme 1.51
3.24
1 year 1.3
Extreme 1.295
3.24
3 years 0.53
Extreme 0.53
3.24
5 years 0.51
Extreme 0.51
7.48
10 years 0.51
Extreme 0.51
19.9
Manager TitleAgeSince
Chief Executive Officer - 22/09/2025
Director of Finance/CFO 42 14/08/2024
Chief Operating Officer 49 31/12/2023
Director TitleAgeSince
Director/Board Member 70 10/06/2018
Director/Board Member 59 10/06/2018
Director/Board Member - 30/06/2019
Date Insider Type Main position Quantity % Market Cap.
04-23Fiscal year

Chief Technology Officer

6,000 0.0063%
04-23Fiscal year

Chief Executive Officer

15,000 0.0159%
04-13Fiscal year

Chief Executive Officer

15,000 0.0159%
Change 5-day change 1-year change 3-year change Capi.($)
-3.77%+0.88%+44.65%+84.00% 226M
+0.44%+2.51%+4.36%+10.27% 50.73B
-1.57%-2.80%+383.82%+582.81% 39.73B
-0.14%+0.25%+27.49%-5.23% 34.69B
+1.76%+2.12%+21.44%+58.27% 33.21B
-0.06%-4.63%+2.94%+31.65% 26.76B
-1.93%-3.38% - - 16.8B
-1.49%-4.92%+63.89%+119.25% 15.37B
+0.78%+0.20%+14.69%+17.08% 13.78B
-0.97%-4.02%+10.35%-31.69% 12.85B
Average -0.55%-0.40%+63.74%+96.27% 24.41B
Weighted average by Cap. +0.05%-0.37%+81.56%+122.97%

Financials

2026 *2027 *
Net sales 9.41M 8.27M 7.67M 7.05M 13.32M 900M 13.61M 91.44M 35.76M 442M 35.35M 34.58M 1.53B 16.05M 14.1M 13.07M 12.02M 22.7M 1.53B 23.19M 156M 60.96M 754M 60.26M 58.94M 2.61B
Net income -27.6M -24.24M -22.48M -20.67M -39.04M -2.64B -39.88M -268M -105M -1.3B -104M -101M -4.48B -28.01M -24.61M -22.82M -20.98M -39.63M -2.68B -40.49M -272M -106M -1.32B -105M -103M -4.55B
Net Debt - -
Logo Compugen Ltd.
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Employees
75
Date Price Change Volume
13/07/26 US$2.300 -3.77% 234,626
10/07/26 US$2.390 -3.24% 158,767
09/07/26 US$2.470 +2.49% 427,749
08/07/26 US$2.410 +0.84% 370,673
07/07/26 US$2.390 +1.27% 220,946
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.300USD
Average target price
4.600USD
Spread / Average Target
+100.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGEN Stock